Last 12 months
Inside the activity.
1 purchase rows · 79 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 17 |
| Jan 2026 | 0 | 8 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 18 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 3 |
| Jun 2026 | 1 | 7 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2022 Filed Aug 3, 2022 01:18 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 49,152 | $14.60 | $717,594.62 |
DisclosureSEC source: 0001209191-22-044009 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,416,239 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 11, 2022 Filed Jul 11, 2022 21:55 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 4,107 | $14.08 | $57,808.08 |
DisclosureSEC source: 0001209191-22-041837 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,465,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.00 to $14.42. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 22:44 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 14,775 | $14.30 | $211,242.61 |
DisclosureSEC source: 0001209191-22-041716 · doc4.xml · nonDerivative · entry 2 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,631,859 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.09 to $14.56. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 22:41 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 20,699 | $14.33 | $296,546.29 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 4 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,469,498 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F6 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.10 to $14.56. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:44 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 25,225 | $14.12 | $356,285.47 |
DisclosureSEC source: 0001209191-22-041716 · doc4.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,646,634 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.00 to $14.35. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:41 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 7,370 | $14.29 | $105,349.73 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,490,197 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.16 to $14.35. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:41 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 42,072 | $13.88 | $583,841.56 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,497,567 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.15 to $14.14. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 22:55 UTC |
Kumar Dinesh M.Chief Med & Operating Officer
|
SaleCommon Stock | 20,000 | $13.04 | $260,786.00 |
DisclosureSEC source: 0001209191-22-041519 · doc4.xml · nonDerivative · entry 2 Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130,970 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported prices in column 4 are weighted-average prices. Shares sold on July 5, 2022 were sold in multiple transactions at a per share price ranging from $12.00 to $12.88. Shares sold on July 6, 2022 were sold in multiple transactions at a per share price ranging from $13.00 to $13.26. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 22:41 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 25,752 | $13.04 | $335,924.54 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,539,639 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.23. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4), (5) and (6) to this Form 4. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:55 UTC |
Kumar Dinesh M.Chief Med & Operating Officer
|
SaleCommon Stock | 16,317 | $12.41 | $202,516.81 |
DisclosureSEC source: 0001209191-22-041519 · doc4.xml · nonDerivative · entry 1 Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,970 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported prices in column 4 are weighted-average prices. Shares sold on July 5, 2022 were sold in multiple transactions at a per share price ranging from $12.00 to $12.88. Shares sold on July 6, 2022 were sold in multiple transactions at a per share price ranging from $13.00 to $13.26. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 18:51 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 20,383 | $12.48 | $254,404.30 |
DisclosureSEC source: 0001209191-22-041516 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 683,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.88. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:06 UTC |
Kumar Dinesh M.Chief Med & Operating Officer
|
SaleCommon Stock | 10,000 | $11.40 | $113,980.00 |
DisclosureSEC source: 0001209191-22-040366 · doc4.xml · nonDerivative · entry 1 Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167,287 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.02 to $11.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 19:04 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 12,000 | $11.40 | $136,838.40 |
DisclosureSEC source: 0001209191-22-040365 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 704,322 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 16:46 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 100 | $12.00 | $1,200.00 |
DisclosureSEC source: 0001209191-22-038918 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 716,322 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 20:54 UTC |
Kumar Dinesh M.Chief Med & Operating Officer
|
SaleCommon Stock | 100 | $12.00 | $1,200.00 |
DisclosureSEC source: 0001209191-22-038942 · doc4.xml · nonDerivative · entry 2 Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177,287 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 16:46 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 3,517 | $12.01 | $42,249.02 |
DisclosureSEC source: 0001209191-22-038918 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 716,422 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:54 UTC |
Kumar Dinesh M.Chief Med & Operating Officer
|
SaleCommon Stock | 3,583 | $12.01 | $43,035.05 |
DisclosureSEC source: 0001209191-22-038942 · doc4.xml · nonDerivative · entry 1 Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177,387 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 17, 2022 Filed Jun 17, 2022 17:55 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 12,000 | $11.18 | $134,114.40 |
DisclosureSEC source: 0001209191-22-038017 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 719,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.03 to $11.35. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:11 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 2,150 | $10.96 | $23,564.00 |
DisclosureSEC source: 0001209191-22-038060 · doc4.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,671,859 F1 · shares: Represents shares sold in a private transaction. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:06 UTC |
Kumar Dinesh M.Chief Med & Operating Officer
|
SaleCommon Stock | 10,000 | $11.04 | $110,393.00 |
DisclosureSEC source: 0001209191-22-038053 · doc4.xml · nonDerivative · entry 1 Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180,970 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:05 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 13,782 | $11.10 | $153,017.41 |
DisclosureSEC source: 0001209191-22-034198 · doc4.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,674,009 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.3250. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| April 26, 2022 Filed May 17, 2022 01:02 UTC |
Maroney Dawn ChristinePresident, Markets
|
GiftCommon Stock | 9,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029454 · doc4.xml · nonDerivative · entry 4 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,687,791 F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to a charitable entity. Read SEC document |
| April 25, 2022 Filed May 17, 2022 01:02 UTC |
Maroney Dawn ChristinePresident, Markets
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029454 · doc4.xml · nonDerivative · entry 3 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,697,206 F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to a charitable entity. Read SEC document |
| April 22, 2022 Filed May 17, 2022 01:02 UTC |
Maroney Dawn ChristinePresident, Markets
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029454 · doc4.xml · nonDerivative · entry 2 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,698,206 F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to a charitable entity. Read SEC document |
| April 12, 2022 Filed May 17, 2022 01:02 UTC |
Maroney Dawn ChristinePresident, Markets
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029454 · doc4.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,699,206 F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to a charitable entity. Read SEC document |
| April 01, 2022 Filed Apr 1, 2022 19:14 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 3,292 | $11.42 | $37,582.13 |
DisclosureSEC source: 0001209191-22-022083 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,269 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares sold on March 31, 2022 were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. Shares sold on April 1, 2022 were sold in multiple transactions at a per share price ranging from $11.31 to $11.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 19:21 UTC |
Shrestha RajeshPres., New Markets & CBO
|
SaleCommon Stock | 14,224 | $11.18 | $158,961.73 |
DisclosureSEC source: 0001209191-22-022092 · doc4.xml · nonDerivative · entry 1 Shrestha Rajesh · CIK 0001879090 · Pres., New Markets & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,220 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 18:47 UTC |
Cross Richard A.SVP, General Counsel
|
SaleCommon Stock | 1,592 | $11.18 | $17,791.56 |
DisclosureSEC source: 0001209191-22-022067 · doc4.xml · nonDerivative · entry 1 Cross Richard A. · CIK 0001879095 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,927 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 19:14 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 4,944 | $11.18 | $55,252.66 |
DisclosureSEC source: 0001209191-22-022083 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,561 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares sold on March 31, 2022 were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. Shares sold on April 1, 2022 were sold in multiple transactions at a per share price ranging from $11.31 to $11.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 23:15 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 6,681 | $11.18 | $74,664.18 |
DisclosureSEC source: 0001209191-22-022084 · doc4.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,714,206 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 18:47 UTC |
Furman Donald StevenChief Clinical Officer
|
SaleCommon Stock | 3,006 | $11.18 | $33,593.85 |
DisclosureSEC source: 0001209191-22-022068 · doc4.xml · nonDerivative · entry 1 Furman Donald Steven · CIK 0001850417 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,826,538 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 23:10 UTC |
Kumar Dinesh M.Chief Medical Officer
|
SaleCommon Stock | 3,058 | $11.18 | $34,175.29 |
DisclosureSEC source: 0001209191-22-022078 · doc4.xml · nonDerivative · entry 1 Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,190,970 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 22:49 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 26,366 | $11.18 | $294,655.87 |
DisclosureSEC source: 0001209191-22-022069 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,353 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:05 UTC |
MARGOLIS JEFFREY HDirector
|
GrantCommon Stock | 19,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017970 · doc4.xml · nonDerivative · entry 1 MARGOLIS JEFFREY H · CIK 0001105688 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,649 F1 · timeliness: Represents 19,316 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:28 UTC |
Cross Richard A.SVP, General Counsel
|
GrantOptions (Right to Buy) · Derivative | 36,496 | $0.00 Strike: $9.06 | $0.00 |
DisclosureSEC source: 0001209191-22-018006 · doc4.xml · derivative · entry 2 Cross Richard A. · CIK 0001879095 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,496 Underlying: Common Stock · 36,496 shares Expires 2032-03-08 F2 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:28 UTC |
Cross Richard A.SVP, General Counsel
|
GrantCommon Stock | 49,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018006 · doc4.xml · nonDerivative · entry 1 Cross Richard A. · CIK 0001879095 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,519 F1 · kind: Represents 49,669 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:23 UTC |
Maroney Dawn ChristinePresident, Markets
|
GrantOptions (Right to Buy) · Derivative | 152,068 | $0.00 Strike: $9.06 | $0.00 |
DisclosureSEC source: 0001209191-22-018002 · doc4.xml · derivative · entry 2 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,068 Underlying: Common Stock · 152,068 shares Expires 2032-03-08 F2 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:23 UTC |
Maroney Dawn ChristinePresident, Markets
|
GrantCommon Stock | 206,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018002 · doc4.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,720,887 F1 · kind: Represents 206,954 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:25 UTC |
Freeman Robert ThomasChief Financial Officer
|
GrantOptions (Right to Buy) · Derivative | 100,365 | $0.00 Strike: $9.06 | $0.00 |
DisclosureSEC source: 0001209191-22-018003 · doc4.xml · derivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,365 Underlying: Common Stock · 100,365 shares Expires 2032-03-08 F3 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:25 UTC |
Freeman Robert ThomasChief Financial Officer
|
GrantCommon Stock | 136,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018003 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,505 F1 · kind: Represents 136,589 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:26 UTC |
Kumar Dinesh M.Chief Medical Officer
|
GrantOptions (Right to Buy) · Derivative | 152,068 | $0.00 Strike: $9.06 | $0.00 |
DisclosureSEC source: 0001209191-22-018005 · doc4.xml · derivative · entry 2 Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,068 Underlying: Common Stock · 152,068 shares Expires 2032-03-08 F2 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:26 UTC |
Kumar Dinesh M.Chief Medical Officer
|
GrantCommon Stock | 206,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018005 · doc4.xml · nonDerivative · entry 1 Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,194,028 F1 · kind: Represents 206,954 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:09 UTC |
McCarthy Margaret MDirector
|
GrantCommon Stock | 16,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017988 · doc4.xml · nonDerivative · entry 1 McCarthy Margaret M · CIK 0001485980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,889 F1 · kind: Represents 16,556 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for five years (or, if earlier, until separation of service or a change of control of the Company). Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 16:50 UTC |
CARELLA THOMAS J.Director
|
GrantCommon Stock | 22,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017936 · doc4.xml · nonDerivative · entry 1 CARELLA THOMAS J. · CIK 0001477767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,408 F1 · kind: Represents 22,075 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:21 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
GrantOptions (Right to Buy) · Derivative | 364,964 | $0.00 Strike: $9.06 | $0.00 |
DisclosureSEC source: 0001209191-22-018000 · doc4.xml · derivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,964 Underlying: Common Stock · 364,964 shares Expires 2032-03-08 F3 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:21 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
GrantCommon Stock | 496,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018000 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,719 F1 · kind: Represents 496,689 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 23:27 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCommon Stock | 16,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018030 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,539 F1 · kind: Represents 16,556 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:01 UTC |
KONOWIECKI JOSEPH SDirector
|
GrantCommon Stock | 33,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017959 · doc4.xml · nonDerivative · entry 1 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 864,997 F1 · kind: Represents 33,113 restricted stock units ("RSUs"), each RSU representing a right to receive one share of Common Stock of the Company. 11,038 RSUs will vest on January 1, 2023, and 22,075 RSUs will vest on the one-year anniversary of the grant date, subject to the reporting person's continued service to the Company on the applicable vesting date. The reporting person has elected to defer receipt of the latter 22,075 underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company). Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 16:48 UTC |
BILNEY JODY LDirector
|
GrantCommon Stock | 16,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017931 · doc4.xml · nonDerivative · entry 1 BILNEY JODY L · CIK 0001185995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,230 F1 · kind: Represents 16,556 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:55 UTC |
JORDEN YONDirector
|
GrantCommon Stock | 22,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017947 · doc4.xml · nonDerivative · entry 1 JORDEN YON · CIK 0001189397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,749 F1 · kind: Represents 22,075 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of 50% of the underlying shares until separation of service as a director (or, if earlier, upon a change of control of the Company). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.